Skip to content

Post-stroke Gait Rehabilitation Using the SHAJA-R Exoskeleton

Post-stroke Gait Rehabilitation With a Unilateral Hip Exoskeleton: Clinical and Neuromuscular Outcomes

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07035730
Acronym
SHAJA-R
Enrollment
20
Registered
2025-06-25
Start date
2025-07-07
Completion date
2026-12-31
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

The goal of this clinical trial is to evaluate the safety, reliability, and short-term effectiveness of SHAJA-based training in improving walking velocity and endurance in post-stroke patients. The main questions it aims to answer are: * Does the SHAJA-based training improve walking velocity and endurance in post-stroke patients compared to conventional gait training? * Is the SHAJA exoskeleton safe and reliable? Researchers will compare the SHAJA-based training to a conventional gait training to see if the former works to improve walking ability. Participants will: * Perform six SHAJA-assisted gait training sessions or six conventional gait training sessions * Perform five assessment sessions

Interventions

DEVICEUnilateral hip exoskeleton

Unilateral hip exoskeleton assisted gait training. Gait training will consist of overground walking with the exoskeleton SHAJA for 30-40 minutes.

Conventional gait training will consist of overground walking without the exoskeleton SHAJA for 30-40 minutes.

Sponsors

Scuola Superiore Sant'Anna di Pisa
CollaboratorOTHER
Centro Riabilitativo Villa Beretta
CollaboratorUNKNOWN
Azienda Ospedaliero, Universitaria Pisana
CollaboratorOTHER
Carmelo Chisari
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* cerebral stroke, at least 3 months from cerebral event * ability to ambulate with no more than minimal contact assistance, even with aids (Functional Ambulation Classification, FAC \>= 43) * self-selected walking velocity in the range \[0.3-0.85\] m/s * anthropometry consistent with the specifications of the tested devices * gait impairments that may benefit from hip assistance, e.g. hip weakness in flexion and/or extension (Medical Research Council, MRC, Scale for Muscle Strength \>2 and \<5 for flexion and extension)

Exclusion criteria

* Modified Ashworth Scale \>3 at the hip and/or ankle joints * Poor cognitive skills (corrected Mini-Mental State Examination, MMSE \< 21) * inability to follow verbal 3 step commands * severe aphasia causing inability to communicate with the investigators * serious medical conditions (recent myocardial infarction in less than 3 months, uncontrolled congestive heart failure (CHF), uncontrolled hypertension, uncontrolled seizures) * leg deep vein thrombosis less than 6 weeks ago * other pre-existing neurological disorders (Parkinson's disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Dementia) * severe anxiety or depression (State-Trait Anxiety Inventory-Y, STAI-Y \> 44, and the Beck Depression Inventory-II, BDI-II \> 19) * severe osteoporosis * severe hip / knee osteoarthritis with limitation of movement or significant pain * use of a colostomy bag * skin wounds, infection, or problems at device contact locations * major orthopaedic surgery or fractures within the last 90 days (hip, knee, ankle, foot, spine) * cardiac surgery within the last 3 months * patient has recently or is currently participating in research that may influence, in PI's opinion, responses to study intervention * pregnancy * implanted cardiac devices, such as pacemakers or automatic defibrillators (AICD) * use of assistive device that, in the PI's opinion, could interfere with SHAJA

Design outcomes

Primary

MeasureTime frame
Changes in fast walking velocity (m/s) pre vs post Conventional training and SHAJA-assisted training interventions assessed with the 10 Metre Walk TestFrom the pre-training evaluation (T1) to the follow up, about 14 weeks after T1
Changes in walking endurance (in minutes) pre vs post Conventional training and SHAJA-assisted training interventions assessed with a Walk TestFrom the pre-training evaluation (T1) to the follow up, about 14 weeks after T1
Changes in self-selected walking velocity (m/s) pre vs post Conventional training and SHAJA-assisted training interventions assessed with the 10 Metre Walk TestFrom the pre-training evaluation (T1) to the follow up, about 14 weeks after T1
Changes in the difference between self-selected and fast walking velocity (delta m/s) pre vs post Conventional training and SHAJA-assisted training interventions assessed with the 10 Metre Walk TestFrom the pre-training evaluation (T1) to the follow up, about 14 weeks after T1
Number of device-related adverse eventsFrom the pre-training evaluation (T1) to the second post-training evaluation, about 3 months after T1
Documenting device hardware and software malfunctionsFrom the pre-training evaluation (T1) to the second post-training evaluation, about 3 months after T1

Secondary

MeasureTime frameDescription
Changes in Modified Ashworth Scale (MAS) pre vs post Conventional training and SHAJA-assisted training interventionsFrom the pre-training evaluation (T1) to the follow up, about 14 weeks after T1The Modified Ashworth Scale ranges from 0 to 4, with lower scores indicating better outcome
Changes in gait kinematics/kinetics pre vs post Conventional training and SHAJA-assisted training interventions assessed with a motion capture systemFrom the pre-training evaluation (T1) to the follow up, about 14 weeks after T1
Changes in the execution time of the Timed-Up-and-Go (TUG) test pre vs post Conventional training and SHAJA-assisted training interventionsFrom the pre-training evaluation (T1) to the follow up, about 14 weeks after T1
Changes in Berg Balance Scale pre vs post Conventional training and SHAJA-assisted training interventionsFrom the pre-training evaluation (T1) to the follow up, about 14 weeks after T1The Berg Balance Scale ranges from 0 to 56, with higher scores indicating better performance
Changes in Motricity Index for Lower Limb pre vs post Conventional training and SHAJA-assisted training interventionsFrom the pre-training evaluation (T1) to the follow up, about 14 weeks after T1The Motricity Index ranges from 0 to 100, with higher scores indicating better performance
Changes in Functional Ambulation Classification (FAC) pre vs post Conventional training and SHAJA-assisted training interventionsFrom the pre-training evaluation (T1) to the follow up, about 14 weeks after T1The Functional Ambulation Classification ranges from 1 to 6, with higher scores indicating better performance

Other

MeasureTime frame
Changes in lower-limb muscle activity through superficial Electromyography (sEMG) pre vs post Conventional training and SHAJA-assisted training interventionsFrom the pre-training evaluation (T1) to the second post-training evaluation, about 3 months after T1
Changes in cortico-muscular connectivity through sEMG and sEEG pre vs post Conventional training and SHAJA-assisted training interventionsFrom the pre-training evaluation (T1) to the second post-training evaluation, about 3 months after T1
Changes in cortico-cortical connectivity through superficial Electroencephalography (sEEG) pre vs post Conventional training and SHAJA-assisted training interventionsFrom the pre-training evaluation (T1) to the second post-training evaluation, about 3 months after T1
Changes in lower-limb muscle synergies pre vs post Conventional training and SHAJA-assisted training interventions assessed by electromyography during walkingFrom the pre-training evaluation (T1) to the second post-training evaluation, about 3 months after T1

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026